4qkh: Difference between revisions

Line 1:

'''~~Unreleased structure~~'''

==Dimeric form of human LLT1, a ligand for NKR-P1==

~~The entry~~ 4qkh is ~~ON HOLD until Paper Publication~~

== Structural highlights ==

<table><tr><td colspan='2'>[[4qkh]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QKH OCA]. For a guided tour on the structure components use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4QKH FirstGlance].

~~Authors~~: ~~Skalova~~, T., ~~Blaha, J~~.~~, Harlos, K~~., ~~Duskova, J~~.~~, Koval, T~~.~~, Stransky, J~~., ~~Hasek, J~~.~~, Vanek, O~~.~~, Dohnalek, J~~.

</td></tr><tr id='ligand'><td class="sblockLbl">[[Ligand|Ligands:]]</td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>

<tr id='related'><td class="sblockLbl">[[Related_structure|Related:]]</td><td class="sblockDat">[[4qkg|4qkg]], [[4qki|4qki]], [[4qkj|4qkj]]</td></tr>

~~Description~~: ~~Dimeric form~~ of ~~human LLT1, a ligand for NKR~~-P1

<tr id='resources'><td class="sblockLbl">Resources:</td><td class="sblockDat">[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qkh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qkh OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4qkh RCSB], [http://www.ebi.ac.uk/pdbsum/4qkh PDBsum]</td></tr>

[[Category: ~~Unreleased Structures~~]]

</table>

== Function ==

[[http://www.uniprot.org/uniprot/CLC2D_HUMAN CLC2D_HUMAN]] Receptor for KLRB1 that protects target cells against natural killer cell-mediated lysis. Inhibits osteoclast formation. Inhibits bone resorption. Modulates the release of interferon-gamma. Binds high molecular weight sulfated glycosaminoglycans.<ref>PMID:14753741</ref> <ref>PMID:15104121</ref> <ref>PMID:16339513</ref>

== References ==

__TOC__

</StructureSection>

[[Category: Blaha, J]]

[[Category: Dohnalek, J]]

[[Category: Duskova, J]]

[[Category: Harlos, K]]

~~[[Category: Stransky, J]]~~

~~[[Category: Blaha, J]]~~

~~[[Category: Vanek, O]]~~

[[Category: Hasek, J]]

[[Category: Koval, T]]

[[Category: Skalova, T]]

[[Category: Stransky, J]]

[[Category: Vanek, O]]

[[Category: Anchored in membrane on cell surface]]

[[Category: C-type lectin like fold]]

[[Category: Deglycosylated after the first glcnac unit]]

[[Category: Glycosylation]]

[[Category: Immune system]]

[[Category: Ligand for human receptor nkr-p1]]

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 1: / Line 1: @@
-'''Unreleased structure'''
+==Dimeric form of human LLT1, a ligand for NKR-P1==
+<StructureSection load='4qkh' size='340' side='right' caption='[[4qkh]], [[Resolution|resolution]] 1.80&Aring;' scene=''>
-The entry 4qkh is ON HOLD  until Paper Publication
+== Structural highlights ==
+<table><tr><td colspan='2'>[[4qkh]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QKH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4QKH FirstGlance]. <br>
-Authors: Skalova, T., Blaha, J., Harlos, K., Duskova, J., Koval, T., Stransky, J., Hasek, J., Vanek, O., Dohnalek, J.
+</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
+<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4qkg|4qkg]], [[4qki|4qki]], [[4qkj|4qkj]]</td></tr>
-Description: Dimeric form of human LLT1, a ligand for NKR-P1
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qkh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qkh OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4qkh RCSB], [http://www.ebi.ac.uk/pdbsum/4qkh PDBsum]</span></td></tr>
-[[Category: Unreleased Structures]]
+</table>
+== Function ==
+[[http://www.uniprot.org/uniprot/CLC2D_HUMAN CLC2D_HUMAN]] Receptor for KLRB1 that protects target cells against natural killer cell-mediated lysis. Inhibits osteoclast formation. Inhibits bone resorption. Modulates the release of interferon-gamma. Binds high molecular weight sulfated glycosaminoglycans.<ref>PMID:14753741</ref> <ref>PMID:15104121</ref> <ref>PMID:16339513</ref>
+== References ==
+<references/>
+__TOC__
+</StructureSection>
+[[Category: Blaha, J]]
 [[Category: Dohnalek, J]]
 [[Category: Duskova, J]]
 [[Category: Harlos, K]]
-[[Category: Stransky, J]]
-[[Category: Blaha, J]]
-[[Category: Vanek, O]]
 [[Category: Hasek, J]]
 [[Category: Koval, T]]
 [[Category: Skalova, T]]
+[[Category: Stransky, J]]
+[[Category: Vanek, O]]
+[[Category: Anchored in membrane on cell surface]]
+[[Category: C-type lectin like fold]]
+[[Category: Deglycosylated after the first glcnac unit]]
+[[Category: Glycosylation]]
+[[Category: Immune system]]
+[[Category: Ligand for human receptor nkr-p1]]